IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 145 filers reported holding IMMUNOGEN INC in Q1 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $272,551 | -25.5% | 17,174 | -11.4% | 0.17% | -23.5% |
Q2 2023 | $365,927 | +60.0% | 19,392 | -67.4% | 0.22% | +72.2% |
Q1 2023 | $228,760 | -21.2% | 59,573 | +1.8% | 0.13% | -17.1% |
Q4 2022 | $290,264 | +87.3% | 58,521 | +80.9% | 0.15% | +145.2% |
Q3 2022 | $155,000 | +7.6% | 32,341 | +0.7% | 0.06% | +17.0% |
Q2 2022 | $144,000 | +22.0% | 32,106 | +29.2% | 0.05% | 0.0% |
Q1 2022 | $118,000 | -39.5% | 24,846 | -5.6% | 0.05% | -28.4% |
Q4 2021 | $195,000 | +6.6% | 26,323 | -18.4% | 0.07% | -8.6% |
Q3 2021 | $183,000 | -18.3% | 32,252 | -5.0% | 0.08% | -12.0% |
Q2 2021 | $224,000 | -33.1% | 33,943 | -17.9% | 0.09% | -34.8% |
Q1 2021 | $335,000 | +27.9% | 41,359 | +1.8% | 0.14% | +29.4% |
Q4 2020 | $262,000 | +3.6% | 40,635 | -42.1% | 0.11% | -18.0% |
Q3 2020 | $253,000 | -31.1% | 70,213 | -12.0% | 0.13% | -23.6% |
Q2 2020 | $367,000 | +7.3% | 79,795 | -20.5% | 0.17% | +23.4% |
Q1 2020 | $342,000 | -41.7% | 100,431 | -12.7% | 0.14% | +46.9% |
Q4 2019 | $587,000 | +90.0% | 115,075 | -9.8% | 0.10% | +54.8% |
Q3 2019 | $309,000 | +5.8% | 127,596 | -5.3% | 0.06% | 0.0% |
Q2 2019 | $292,000 | +114.7% | 134,704 | +169.2% | 0.06% | -78.5% |
Q1 2019 | $136,000 | -50.2% | 50,045 | -12.0% | 0.29% | +514.9% |
Q4 2018 | $273,000 | -36.1% | 56,871 | +26.1% | 0.05% | +6.8% |
Q3 2018 | $427,000 | -43.3% | 45,112 | -41.7% | 0.04% | -93.4% |
Q2 2018 | $753,000 | -36.4% | 77,365 | -31.3% | 0.67% | -35.2% |
Q1 2018 | $1,184,000 | +242.2% | 112,547 | +108.5% | 1.03% | +136.6% |
Q4 2017 | $346,000 | -35.4% | 53,977 | -22.9% | 0.43% | +502.8% |
Q3 2017 | $536,000 | +18.6% | 70,035 | +10.1% | 0.07% | +7.5% |
Q2 2017 | $452,000 | +137.9% | 63,629 | -10.1% | 0.07% | -27.2% |
Q3 2016 | $190,000 | -12.8% | 70,796 | 0.0% | 0.09% | -43.2% |
Q2 2016 | $218,000 | +32.9% | 70,796 | +267.6% | 0.16% | -28.3% |
Q1 2016 | $164,000 | – | 19,257 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |